Endocrine Abstracts

Background: Woman with Polycystic Ovarian Syndrome (PCOS) are at risk of developingmetabolic syndrome (MetS), insulin resistance, dyslipidemia, Type 2 Diabetes and Cardiovascular Disease. Atherogenic dyslipidemia occurs in > 70% of women with PCOS which includes high fasting plasma TG, LDL-C, non-HDL-C or ApoB, and low HDL-C. In addition to diet and lifestyle as the first-line intervention, metformin is commonly prescribed for impaired glucose sensitivity. However, metform...